01 Industry overview
The wound care industry at a glance
The global wound care market is estimated at $26.1 billion in 2026 and is forecast to reach $35.1 billion by 2033, reflecting continued demand for chronic-wound treatment and advanced dressings.
- $26.1B[2]
- Global market estimate, 2026
- 4.3%[2]
- Forecast CAGR, 2026–2033
- 46.9%[2]
- North America share, 2025
- $1.793B[13]
- Smith+Nephew wound revenue, 2025
- Market size
- Grand View Research estimates the global wound care market at $25.1 billion in 2025 and $26.1 billion in 2026. A separate Frost & Sullivan industry overview filed with the Hong Kong Stock Exchange estimates the broader global wound care products market at $26.5 billion in FY2026.[2][14]
- Forecast & CAGR
- The global market is projected to reach $35.1 billion by 2033 at a 4.3% CAGR from 2026 to 2033. Frost & Sullivan forecasts the wound care products market to reach $35.8 billion by FY2031, implying a 6.1% CAGR from FY2027 to FY2031.[2][14]
- Market share & regions
- North America accounted for 46.9% of global wound care revenue in 2025, the largest regional share. Asia Pacific is identified as the fastest-growing region during 2026–2033.[2]
- Segmentation
- Chronic wounds represented 59.8% of the market in 2025, while hospitals accounted for 36.4% of end-use revenue. Advanced wound dressings were the largest product segment, and prescribed products and institutional sales led their respective channels.[2]
- Pricing
- For Medicare outpatient payment in 2026, CMS established a single payment rate of $127.14 per square centimeter for the three main categories of skin-substitute products: PMA, 510(k), and 361 HCT/P products. This replaces product-specific pricing approaches for the affected categories and may increase pricing pressure.[15]
- Trends, drivers & challenges
- Growth is being supported by chronic wounds, diabetes, aging populations, and adoption of advanced dressings and wound-therapy devices. The market also faces reimbursement pressure: CMS changed 2026 payment rules for skin substitutes and aligned payment categories with FDA regulatory status.[2][15]
- Consumer behavior & competition
- Purchasing remains concentrated in institutional care: hospitals represented 36.4% of end-use revenue in 2025, while institutional sales were the leading distribution channel and prescribed products led mode of purchase. Major named competitors include Smith+Nephew, Convatec, Mölnlycke, Baxter, Coloplast, Medtronic, 3M, Integra LifeSciences, Medline, Cardinal Health, and Organogenesis.[2]
- M&A
- BioStem Technologies completed the acquisition of selected surgical and wound-care assets from BioTissue on January 21, 2026, including the Neox and Clarix trademarks, related intellectual property, and commercial infrastructure. The transaction also provided rights to the Catalyze advanced wound-care device after its June 2026 510(k) clearance, subject to up to $10.0 million in additional consideration.[13]
- Regulation
- For calendar year 2026, CMS finalized payment changes for skin substitutes in hospital outpatient and physician-office settings, categorizing products according to FDA pathways including PMA, 510(k), and 361 HCT/P. CMS also set a single $127.14-per-square-centimeter rate for the three categories in the outpatient payment schedule.[15]
- Latest news
- In October 2026, the FDA cleared Restrata for a 510(k) indication, and Solventum announced clearance for combined use of Restrata Synthetic Electrospun Fiber Matrix with V.A.C. Therapy. The development followed Solventum’s December 2025 acquisition of Acera Surgical and illustrates ongoing consolidation around advanced wound-healing platforms.[16][17]
02 Ranking
Top 10 Companies in the Wound Care Industry
The leading companies in the wound care industry, ranked on market impact, performance, momentum, innovation and brand popularity.
Updated November 17, 2026 · Next review December 17, 2026
Medline stands out for wound-care coverage because it sells wound-care products within a 335,000-product med-surg portfolio, while Smith+Nephew focuses on advanced wound care since its wound revenue reached $1.793B in 2025.
Ranked by Overall score · How we score ↓
Editor's top 3 picks
Where to start, by need.
#1 Overall · Leader in market supply catalogs
Medline
US
Ranked #1 · 9.6 · Market supply catalogs
Why we picked it: Its wound-care offering sits inside a 335,000-product med-surg catalog, giving coverage across care settings.
Leader in wound devices & therapy
Smith+Nephew
GB
Ranked #2 · 9.1 · Wound devices & therapy
Why we picked it: Its advanced wound care segment is reflected in $1.793B in Smith+Nephew wound revenue in 2025.
Leader in advanced wound dressings
Convatec
GB
Ranked #3 · 9.1 · Advanced wound dressings
Why we picked it: Its wound-care line is backed by $753 million of 2025 Advanced Wound Care revenue.
Pick 1 is the #1 company overall. Picks 2 and 3 are the highest-ranked companies in the top 5 that add a new segment.
Full ranking
| # | Company | Overall ↓ | Impact | Performance | Momentum | Innovation | Company snapshot |
|---|---|---|---|---|---|---|---|
| 1 | Medline Market supply catalogs · US | 9.6 | 9.9 | 9.9 | 9.9 | 9.1 | |
Company snapshot · Medline · Data as of November 17, 2026 Medline sells wound-care products within a 335,000-product med-surg portfolio.[18]
| |||||||
| 2 | Smith+Nephew Wound devices & therapy · GB | 9.1 | 9.1 | 8.8 | 9.7 | 9.9 | |
Company snapshot · Smith+Nephew · Data as of November 17, 2026 Smith+Nephew says it has the second-largest global wound-care business by revenue.[13]
| |||||||
| 3 | Convatec Advanced wound dressings · GB | 9.1 | 9.2 | 8.8 | 9.7 | 9.1 | |
Company snapshot · Convatec · Data as of November 17, 2026 Convatec reported $753 million of 2025 Advanced Wound Care revenue.[19]
| |||||||
| 4 | Coloplast Advanced wound dressings · DK | 8.9 | 8.6 | 9.8 | 8.3 | 9.9 | |
Company snapshot · Coloplast · Data as of November 17, 2026 Coloplast reported DKK 3.849 billion in 2025/26 Wound & Tissue Repair revenue.[20]
| |||||||
| 5 | Solventum Wound devices & therapy · US | 8.9 | 9.1 | 9.4 | 7.8 | 8.4 | |
Company snapshot · Solventum · Data as of November 17, 2026 Solventum reports $1.883 billion in 2025 Advanced Wound Care sales.[17]
| |||||||
| 6 | Lohmann & Rauscher Dressings, compression and negative-pressure therapy · DE | 8.4 | 8.5 | 8.1 | 8.7 | 8.2 | |
Company snapshot · Lohmann & Rauscher · Data as of November 17, 2026 L&R develops and manufactures wound-care, bandage and negative-pressure products.[21]
| |||||||
| 7 | Mölnlycke Health Care Advanced dressings and wound-care solutions · SE | 8.3 | 8.9 | 7.7 | 9.0 | 7.0 | |
Company snapshot · Mölnlycke Health Care · Data as of November 17, 2026 Mölnlycke describes itself as a world-leading MedTech company focused on wound care and surgical solutions.[22]
| |||||||
| 8 | Hollister Ostomy, continence and wound-care products · US | 8.3 | 7.0 | 9.8 | 8.7 | 8.2 | |
Company snapshot · Hollister · Data as of November 17, 2026 Hollister develops, manufactures and markets wound-care products worldwide.[23]
| |||||||
| 9 | Organogenesis Advanced wound-care biologics · US | 8.2 | 7.8 | 9.6 | 7.3 | 8.2 | |
Company snapshot · Organogenesis · Data as of November 17, 2026 Organogenesis generated $531.2 million in 2025 Advanced Wound Care product revenue.[24]
| |||||||
| 10 | Integra LifeSciences Wound reconstruction and regenerative care · US | 7.8 | 8.5 | 7.0 | 7.0 | 7.8 | |
Company snapshot · Integra LifeSciences · Data as of November 17, 2026 Integra reported $323.5 million in 2025 Wound Reconstruction and Care revenue.[25]
| |||||||
How we score
- Impact (30%): scale and weight in the market (revenue, market share, employees, market position).
- Performance (20%): recent revenue growth and operating margin; an analyst assessment where a company does not publish them.
- Momentum (20%): growth trajectory and future potential.
- Innovation (15%): R&D intensity and how technologically advanced the company is.
Popularity (brand search demand, 15%) counts toward Overall but is not published as a column. Overall leaves out what is not known.
Scale Scores are shown on a 7–10 scale with one decimal; bars start at 7.0.
Cadence Recalculated when new figures are published; next review December 17, 2026.
Independence. Rankings are editorially independent. Scores, ranks, picks and the verdict follow the method above; no company can pay to change them.
Cite this ranking
APA
Helena Kowalczyk. (2026, February 13). Top 10 companies in the wound care industry. In Wound Care Industry Statistics. Gitnux. https://gitnux.org/wound-care-industry-statistics/#top-companies
Global surgical wound care market size
Global surgical wound care market size grew from $6.1B in 2023 to $6.3B in 2024.
03 Trends & forecasts
Top 10 Wound Care Industry Trends & Forecasts 2027
What is changing in the wound care industry, with the evidence behind each trend and a forecast for 2027.
Forecasts were generated by an AI model from the cited evidence. They are estimates, not guarantees.
01Global demand grows steadily
High confidenceGrand View Research estimates the global wound care market at $26.1 billion in 2026, up from $25.1 billion in 2025, and projects $35.1 billion by 2033 at a 4.3% CAGR. The expansion reflects persistent demand for chronic-wound treatment and advanced products.[2]
Forecast 2027: The market should reach approximately $27.2 billion in 2027 if it follows the reported 4.3% medium-term CAGR. Growth will remain positive but moderate rather than accelerate sharply.
02Chronic wounds remain dominant
High confidenceChronic wounds represented 59.8% of global wound care revenue in 2025, according to Grand View Research. Diabetic foot ulcers, pressure injuries and venous leg ulcers require prolonged treatment and support recurring product demand.[2]
Forecast 2027: Chronic-wound products should continue to account for roughly 60% of market revenue in 2027. Demand will favor products that demonstrate faster healing, infection control or lower total treatment costs.
03Diabetes sustains ulcer demand
High confidenceThe CDC estimated that 40.1 million people in the United States had diagnosed or undiagnosed diabetes in 2023, equal to 12.0% of the population; 11.0 million adults were undiagnosed. This expands the population at risk of diabetic foot ulcers and delayed healing.[26]
Forecast 2027: In 2027, diabetic-wound management should remain one of the fastest-growing chronic-care applications. Screening, off-loading, infection management and advanced dressings will receive increasing attention from providers and payers.
04Asia Pacific expands fastest
High confidenceAsia Pacific is identified as the fastest-growing regional wound care market for 2026–2033. Its chronic wound care segment is projected to grow at a 4.8% CAGR from 2026 to 2033, reaching $3.4166 billion by 2033 from $2.4550 billion in 2026.[2]
Forecast 2027: Asia Pacific should add approximately $0.12 billion in chronic wound care revenue in 2027 at the cited growth rate. Suppliers will prioritize China, Japan, India and other markets where diabetes, aging and healthcare access are expanding.
05North America retains leadership
High confidenceNorth America held 46.9% of global wound care revenue in 2025, making it the largest regional market. The United States also remains a major center for advanced product commercialization and reimbursement policy development.[2]
Forecast 2027: North America should remain the largest regional market in 2027, although its share is likely to edge down as Asia Pacific grows faster. Competitive intensity will remain highest in U.S. hospitals, wound clinics and physician offices.
06Advanced dressings lead mix
High confidenceAdvanced wound dressings were the largest product segment in 2025. In Asia Pacific chronic wound care, advanced wound dressing was also the largest product segment and the fastest-growing product category during the forecast period.[2]
Forecast 2027: Advanced dressings should gain further share in 2027 as providers seek fewer dressing changes, improved exudate control and better clinical workflows. Foam, collagen, antimicrobial and moisture-management formats are likely to remain the main growth areas.
07Negative-pressure therapy broadens
High confidenceGrand View Research identifies negative-pressure wound therapy among the technologies supporting chronic wound care growth. Smith+Nephew reported 2025 Advanced Wound Devices revenue of $406 million, up 11.1% on a reported basis and 9.8% on an underlying basis.[2][27]
Forecast 2027: NPWT should continue growing faster than basic wound-care products in 2027, supported by hospital use and increasingly portable systems. Growth will favor platforms that combine therapy, dressings, data capture and easier outpatient or home use.
08Synthetic matrices gain momentum
Medium confidenceThe FDA recorded a 510(k) decision for Restrata on October 16, 2026, classifying it as an absorbable synthetic wound dressing. Solventum also announced FDA clearance on October 19, 2026, for combined use of Restrata Synthetic Electrospun Fiber Matrix with V.A.C. Therapy.[16][17]
Forecast 2027: In 2027, synthetic and resorbable matrices should see broader adoption, particularly when paired with established therapy systems. Clinical differentiation and reimbursement evidence will determine whether new matrices displace incumbent biologic products.
09Product-platform consolidation accelerates
Medium confidenceSolventum’s Restrata clearance followed its December 2025 acquisition of Acera Surgical, bringing a synthetic matrix into a broader advanced wound-healing platform. Smith+Nephew generated $1.793 billion in Advanced Wound Management revenue in 2025, showing the scale available to diversified suppliers.[17][27]
Forecast 2027: Further acquisitions, licensing deals and co-commercialization agreements are likely in 2027. Buyers will favor assets that add differentiated matrices, devices, clinical evidence or access to specialist wound-care channels.
10Medicare pricing pressure intensifies
High confidenceFor calendar year 2026, CMS established a single $127.14-per-square-centimeter payment rate for PMA, 510(k) and 361 HCT/P skin-substitute categories in hospital outpatient settings. CMS said the policy was intended to create a consistent approach across care settings and reduce excessive payment variation.[15]
Forecast 2027: In 2027, manufacturers and providers should face continued pressure to justify product prices with outcomes and resource-use data. Lower-priced alternatives and products with clearer evidence may gain share, while marginal products may experience reduced utilization.
04 Statistics
Market Intelligence
This section separates wound care centers from the wider wound care products market and includes observed U.S. clinic and provider counts. It also shows wound care centers projected to grow from $48.7 billion in 2026 to $62.4 billion by 2033.
Market size and service revenue in the wound care industry
- $45.35 billion was the global wound care centers market in 2025, covering providers of wound care center services; North America was the largest regional market.[1]
- $47.0 billion was the global wound care centers market in 2025, covering hospitals and clinics delivering specialized dressings, negative-pressure therapy and compression therapy; North America represented approximately 45.0%.[2]
- $15.50 billion was the U.S. wound care centers market in 2025, covering wound care center services; hyperbaric oxygen therapy accounted for 31.13% of revenue.[2]
Growth forecasts for the wound care industry
- The global wound care centers market is projected to grow from $48.7 billion in 2026 to $62.4 billion in 2033, a 3.6% CAGR; the study covers hospitals and clinics providing wound care services.[2]
- The global wound care centers market is projected to grow from $45.35 billion in 2025 to $57.26 billion in 2030, a 4.6% CAGR; the category covers specialized wound care centers and outpatient clinics.[1]
- The global wound care market is projected to grow from $22.22 billion in 2025 to $30.48 billion in 2030, a 6.5% CAGR; the publisher’s category includes wound care products and associated treatment applications.[3]
Firm counts and size structure in the wound care industry
- 355 U.S. wound care clinic companies were identified as of September 22, 2026, using exact business-description matches; the observed population had a median company size of 11–50 employees.[4]
- 787 wound care providers were listed across all 50 U.S. states in the NPPES-derived Wound Clinic Finder dataset, as counted in the source’s latest published statistics.[5]
- 137 of 355 U.S. wound care clinic companies had 1–10 employees as of September 22, 2026, based on RevenueBase’s observed company graph.[4]
Demand shifts in the wound care industry
- Surgical wounds’ share of wound care episodes at 11 participating U.S. home-health branches fell from 48.4% in March–October 2022 to 46.8% in the same 2023 period.[6]
- Pressure-injury episodes’ share at 11 participating U.S. home-health branches rose from 18.9% in March–October 2022 to 20.5% in March–October 2023.[6]
- Surgical-wound episodes at participating U.S. home-health branches increased from 1,374 of 3,958 episodes to 1,435 of 5,429 episodes between the pre-adoption and post-adoption periods reported in the study.[7]
05 Statistics
Operating Benchmarks
This section quantifies managed episodes and patient admissions around digital wound-care provisioning in a U.S. home-health cohort. It reports 22,193 wound care episodes managed from March–October 2023.
Operating metrics used in the wound care industry
- 22,193 wound care episodes were managed from March–October 2023 at 11 U.S. home-health branches implementing a digital wound-care solution.[6]
- 5,429 wound episodes were managed during the post-adoption period at participating U.S. home-health branches in the study’s November 2021–May 2022 comparison cohort.[7]
- 16,276 patients were admitted for wound care from March–October 2023 at 11 U.S. home-health branches implementing a digital wound-care solution.[6]
06 Statistics
Delivery & Operations
This section documents the measured installed base of wound care clinics and practitioner capacity in 2026. It lists 628 wound care centers analyzed across the United States in 2026.
Delivery capacity and installed base in the wound care industry
- 118 Healogics wound care clinics were identified across 14 northeastern U.S. states and the District of Columbia in November 2022, providing a regional installed-base measure.[8]
- 628 wound care centers were analyzed across the United States in 2026, representing the observed national specialized-care delivery-site base.[9]
- 2,776 providers were included across the 628 analyzed U.S. wound care centers in 2026, representing qualified practitioner capacity.[9]
- 492 providers were identified across 118 Healogics wound care clinics in the northeastern United States and Washington, D.C., in November 2022.[8]
07 Statistics
People & Workforce
This section shows certification population counts for physicians, nurses, and wound-care professionals across ABWM and WOCNCB. It reports 8,523 nurses holding the Certified Wound Care Nurse credential at December 31, 2025.
Skills and certification in the wound care industry
- 1,250 physicians held the Certified Wound Specialist Physician credential at December 31, 2025, in the ABWM certification population.[10]
- 2,808 professionals held the Certified Wound Specialist credential at December 31, 2025, in the ABWM certification population.[10]
- 8,523 nurses held the Certified Wound Care Nurse credential at December 31, 2025, in the WOCNCB certification population.[11]
- 1,399 wound-care nurse examinations were administered in 2025, with a 70.52% pass rate, in the WOCNCB certification population.[11]
- 657 professionals held the Certified Wound Care Associate credential at December 31, 2025, in the ABWM certification population.[10]
08 Statistics
Pricing
This section provides participating Medicare physician payment amounts by CPT and locality, supporting operational budgeting. It includes $244.61 for CPT 11043 muscle-and-tissue wound debridement in Michigan locality 01.
Fees and price levels in the wound care industry
- $244.61 is the 2026 participating Medicare physician payment for CPT 11043 muscle-and-tissue wound debridement in Michigan locality 01, facility setting.[12]
- $132.56 is the 2026 participating Medicare physician payment for CPT 11042 subcutaneous-tissue wound debridement in Michigan locality 01, facility setting.[12]
- $329.51 is the 2026 participating Medicare physician payment for CPT 11044 muscle-and-bone wound debridement in Michigan locality 01, facility setting.[12]
Key questions about the Wound Care Industry
What is the 2026 global wound care market size?
How fast does the market grow from 2026 to 2033?
Which companies lead the wound care industry?
What technology shifts affect reimbursement and adoption in 2026?
How is the market structured by end use and product type?
Where do buyers concentrate and what drives purchasing mode?
Cite This Report
This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.
Helena Kowalczyk. (2026, February 13). Wound Care Industry Statistics. Gitnux. https://gitnux.org/wound-care-industry-statistics
Helena Kowalczyk. "Wound Care Industry Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/wound-care-industry-statistics.
Helena Kowalczyk. 2026. "Wound Care Industry Statistics." Gitnux. https://gitnux.org/wound-care-industry-statistics.
Sources & references
27 sources cited across this report
thebusinessresearchcompany.com
grandviewresearch.com
prnewswire.com
revenuebase.ai
woundclinicfinder.com
mdpi.com
nursing.jmir.org
pubmed.ncbi.nlm.nih.gov
doi.org
abwmcertified.org
wocncb.org
msho.org
sec.gov
www1.hkexnews.hk
cms.gov
accessdata.fda.gov
investors.solventum.com
ir.medline.com
convatecgroup.com
coloplast.com
lohmann-rauscher.com
molnlycke.com
hollister.com
investors.organogenesis.com
investor.integralife.com
cdc.gov
smith-nephew.stylelabs.cloud
